Increased Risk of Atrial Fibrillation for Multiple Myeloma Patients

LIFE WITH MYELOMA - June 17, 2021

There's additional risk of developing atrial fibrillation (AF) for patients with certain types of cancers including multiple myeloma, according to Kore... Read More

Tools for Good Balance and Fall Prevention for Myeloma Patients

Statistically, multiple myeloma is more prevalent in the older population.  Age alone brings about many changes in health.  A diagnosis and treatment ... Read More

HealthTree University: MRD Testing (Part 2/3)

Understanding your Minimal Residual Disease status, and understanding what MRD testing is and what it means is critical to the future of myeloma and your myelom... Read More

ASCO/EHA Meeting Review: Register Now for the Myeloma Crowd Round Table Webcast on June 26


Six Myeloma Experts Discuss ASCO/EHA Studies   Register Now   The annual meetings of the American Society of Clinical Oncology (ASCO) and ... Read More

ASCO 2021: BiSpecific Antibodies Expand Immunotherapy Options for Relapsed/Refractory Myeloma Patients

MYELOMA NEWS - June 15, 2021

In a prior article, we shared that a new off-the-shelf bispecific antibody targeting BCMA by Janssen (teclistimab) just received Breakthrough Therapy Desig... Read More

ASCO 2021: MRD Negativity, Going with the Flow, NGS, Mass Spec, or PET

LIFE WITH MYELOMA - June 15, 2021

What Is MRD? Minimal residual disease (MRD), sometimes called measurable residual disease, refers to a measurement of myeloma cells that remain after treatm... Read More

New CAR T Therapy Shows 100% Overall Response Rate in Relapsed and Refractory Multiple Myeloma

MYELOMA NEWS - June 14, 2021

It is hard to keep up with the recent developments of CAR-T products used in relapsed/refractory multiple myeloma (RRMM) patients, but an exciting new CAR-... Read More

ASCO 2021: Considerations for Older Multiple Myeloma Patients

LIFE WITH MYELOMA - June 12, 2021

Multiple myeloma is more prevalent in the older population; the median age of diagnosis is 69 years, and 35% of patients are age 75 or older at diagnosis.1 ... Read More

Multiple Myeloma Cases Double Worldwide Since 1990

LIFE WITH MYELOMA - June 10, 2021

According to Chinese myeloma researchers, the global incidence of multiple myeloma has more than doubled globally since 1990. In a study, data from the 201... Read More

Medical Bills, Collections and Your Credit Score

MYELOMA COACH - June 09, 2021

Many people don’t realize that their credit report may contain medical bills in collection that can seriously effect their credit score. Even if you&rsquo... Read More

Full Show: Using Monoclonal Antibodies in Newly Diagnosed Multiple Myeloma with Peter Voorhees, MD, Levine Cancer Institute

MC RADIO - June 09, 2021

Peter Voorhees, MD Levine Cancer Institute - Atrium Health Interview Date: May 18, 2021 Thanks to our episode sponsor Summary Quad therapies (fou... Read More

ASCO 2021: FDA grants Breakthrough Therapy Designation to Teclistamab, a Bispecific Antibody for Relapsed or Refractory Multiple Myeloma

MYELOMA NEWS - June 06, 2021

Teclistamab, an off-the shelf bispecific antibody targeting BCMA by Janssen, has received Breakthrough Therapy Designation from the FDA. This designation f... Read More

Salvage Therapy for Aggressive Types of Multiple Myeloma: Plasma Cell Leukemia and Extramedullary Myeloma

MYELOMA NEWS - June 04, 2021

What is "salvage therapy"? The Dictionary of the National Cancer Institute defines “Salvage Therapy” as “Treatment that is give... Read More

Find Myeloma Help

Myeloma Financial Resource


Find financial resources like housing, prescription and patient assistance programs and other helpful links that will guide you through your myeloma care.

Myeloma Specialist


Patients who are seen by myeloma specialists live longer. Find a myeloma specialists closest to you and add them to your care team for your best outcomes.

Myeloma Clinical Trials


Find personally relevant treatment options and clinical trials at every stage of your myeloma with HealthTree and SparkCures.

Myeloma Coach


We're a team of myeloma patient and caregiver volunteers who can help you find and use the best myeloma resources so you can better navigate your myeloma care.

Thanks to our Myeloma Crowd Community sponsors:

.                         .